Compare NeoGenomics Inc. Common Stock (NEO) vs Valaris Limited Common Shares (VAL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
NeoGenomics Inc. Common Stock vs Valaris Limited Common Shares — how do they compare? NeoGenomics Inc. Common Stock trades at $16.85 (market cap $2.14B), while Valaris Limited Common Shares trades at $84.73 (market cap $5.94B). The key difference: Valaris Limited Common Shares is far larger — about 2.8× NeoGenomics Inc. Common Stock's market cap, and NeoGenomics Inc. Common Stock is trading nearer its 52-week high, Valaris Limited Common Shares nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold NeoGenomics Inc. Common Stock for 0 Days and Valaris Limited Common Shares for 0 Days on average.
| NEO | VAL | |
|---|---|---|
Market Cap | $2.14B | $5.94B |
Volume | 2,228,400 | 742,554 |
Sector | Health | Energy |
52-Week High | $19.91 | $113.42 |
52-Week Low | $7.19 | $48.15 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $2.44B | $6.56B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About NeoGenomics Inc. Common Stock
NeoGenomics, Inc. is a US cancer diagnostics company that provides genomic and pathology testing services, offering an oncology-focused testing menu used by oncologists, pathologists, and hospital systems across the cancer care continuum.
Read more on NEO →About Valaris Limited Common Shares
Valaris Limited provides offshore contract drilling services to the oil and gas industry, operating a fleet of drillships, semisubmersibles, and jackup rigs across multiple regions worldwide.
Read more on VAL →
